Stock Market News

Glenmark launches Clindamycin Phosphate Foam, a bioequivalent to Evoclin

Feb 12, 2025 - 14:44
 0
Glenmark launches Clindamycin Phosphate Foam, a bioequivalent to Evoclin
Read More

Tags:

Previous Article

US stock futures slump after strong CPI release; Powell to speak again

Next Article

Fluence Energy faces wave of downgrades on margin, growth concerns

Related Posts

Baidu to roll out next-gen AI model this year amid grow...

Feb 12, 2025  0

Taiwan stocks higher at close of trade; Taiwan Weighted up 0.69%

Taiwan stocks higher at close of trade; Taiwan Weighted...

Feb 10, 2025  0

China tops hedge funds' shopping lists so far this year, Goldman says

China tops hedge funds' shopping lists so far this year...

Feb 11, 2025  0